Yang H - Search Results

1

Blocking cell cycle progression through CDK4/6 protects against chronic kidney disease.

Osaki Y, Manolopoulou M, Ivanova AV, Vartanian N, Mignemi MP, Kern J, Chen J, Yang H, Fogo AB, Zhang M, Robinson-Cohen C, Gewin LS. Osaki Y, et al. Among authors: yang h. JCI Insight. 2022 Jun 22;7(12):e158754. doi: 10.1172/jci.insight.158754. JCI Insight. 2022. PMID: 35730565 Free PMC article.

2

Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.

Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D, Fogo AB. Ma LJ, et al. Among authors: yang h. Am J Pathol. 2003 Oct;163(4):1261-73. doi: 10.1016/s0002-9440(10)63486-4. Am J Pathol. 2003. PMID: 14507636 Free PMC article.

3

Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.

Ma LJ, Nakamura S, Aldigier JC, Rossini M, Yang H, Liang X, Nakamura I, Marcantoni C, Fogo AB. Ma LJ, et al. Among authors: yang h. J Am Soc Nephrol. 2005 Apr;16(4):966-76. doi: 10.1681/ASN.2004060492. Epub 2005 Feb 23. J Am Soc Nephrol. 2005. PMID: 15728787

4

Effects of podocyte injury on glomerular development.

Ma J, Rossini M, Yang HC, Zuo Y, Fogo AB, Ichikawa I. Ma J, et al. Pediatr Res. 2007 Oct;62(4):417-21. doi: 10.1203/PDR.0b013e31813cbed1. Pediatr Res. 2007. PMID: 17667850

5

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

Yang HC, Deleuze S, Zuo Y, Potthoff SA, Ma LJ, Fogo AB. Yang HC, et al. J Am Soc Nephrol. 2009 Nov;20(11):2380-8. doi: 10.1681/ASN.2008111138. Epub 2009 Oct 1. J Am Soc Nephrol. 2009. PMID: 19797472 Free PMC article.

6

Dystroglycan in the diagnosis of FSGS.

Giannico G, Yang H, Neilson EG, Fogo AB. Giannico G, et al. Among authors: yang h. Clin J Am Soc Nephrol. 2009 Nov;4(11):1747-53. doi: 10.2215/CJN.01510209. Epub 2009 Sep 24. Clin J Am Soc Nephrol. 2009. PMID: 19808230 Free PMC article.

7

Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.

Naito T, Ma LJ, Yang H, Zuo Y, Tang Y, Han JY, Kon V, Fogo AB. Naito T, et al. Among authors: yang h. Am J Physiol Renal Physiol. 2010 Mar;298(3):F683-91. doi: 10.1152/ajprenal.00503.2009. Epub 2009 Dec 30. Am J Physiol Renal Physiol. 2010. PMID: 20042458 Free PMC article.

8

Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.

Rossini M, Naito T, Yang H, Freeman M, Donnert E, Ma LJ, Dunn SR, Sharma K, Fogo AB. Rossini M, et al. Among authors: yang h. Nephrol Dial Transplant. 2010 Jun;25(6):1803-10. doi: 10.1093/ndt/gfp724. Epub 2010 Jan 7. Nephrol Dial Transplant. 2010. PMID: 20061322 Free PMC article.

9

'Idiopathic' FSGS: an increasingly obsolete diagnosis?

Yang HC, Fogo AB. Yang HC, et al. Nephrol Dial Transplant. 2010 Mar;25(3):654-6. doi: 10.1093/ndt/gfp750. Epub 2010 Jan 18. Nephrol Dial Transplant. 2010. PMID: 20083472 No abstract available.

10

Sirt1 activation protects the mouse renal medulla from oxidative injury.

He W, Wang Y, Zhang MZ, You L, Davis LS, Fan H, Yang HC, Fogo AB, Zent R, Harris RC, Breyer MD, Hao CM. He W, et al. Among authors: yang hc. J Clin Invest. 2010 Apr;120(4):1056-68. doi: 10.1172/JCI41563. Epub 2010 Mar 24. J Clin Invest. 2010. PMID: 20335659 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60,972 results

Search Page

Filters